(Q84238187)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20476917%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

title

S100 proteins in the pathogenesis and diagnosis of inflammatory bowel disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20476917%20AND%20SRC:MED&resulttype=core&format=json

inflammatory bowel diseases

2 February 2020

main subject

1 reference

based on heuristic

inferred from title

publication date

1 May 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20476917%20AND%20SRC:MED&resulttype=core&format=json

Expert Review of Clinical Immunology

2 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20476917%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

volume

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20476917%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20476917%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

page(s)

471-480

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20476917%20AND%20SRC:MED&resulttype=core&format=json

Incidence, clinical presentation and location at diagnosis of pediatric inflammatory bowel disease: a prospective population-based study in northern France (1988-1999).

2 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2.3.471

NOD2 mutations and Crohn's disease: are Paneth cells and their antimicrobial peptides the link?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2.3.471

The epidemiology and phenotype of Crohn's disease in the Chinese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2.3.471

Meta-analysis of enteral nutrition as a primary treatment of active crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2.3.471

Presenting symptoms and diagnostic lag in children with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2.3.471

Identification of a prodromal period in Crohn's disease but not ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2.3.471

Longitudinal growth in children and adolescents with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2.3.471

Puberty in chronically diseased patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2.3.471

Adult height in patients with early onset of Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2.3.471

Inflammatory bowel disease in children 5 years of age and younger

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2.3.471

Problems in diagnosis of IBD in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2.3.471

Psychiatric presentation of Crohn's disease. Diagnostic delay and increased morbidity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2.3.471

Electrophoretic analysis of acute-phase plasma proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2.3.471

Enteric protein loss measured by fecal alpha 1-antitrypsin clearance in the assessment of Crohn's disease activity: a study of children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2.3.471

A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2.3.471

Cytokines in stools of children with inflammatory bowel disease or infective diarrhoea

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2.3.471

Detection of pro- and anti-inflammatory cytokines in stools of patients with inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2.3.471

Inflammatory bowel disease: etiology and pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2.3.471

A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2.3.471

Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2.3.471

hPepT1 transports muramyl dipeptide, activating NF-kappaB and stimulating IL-8 secretion in human colonic Caco2/bbe cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2.3.471

NOD2 is a negative regulator of Toll-like receptor 2-mediated T helper type 1 responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2.3.471

NOD2 (CARD15) mutations in Crohn's disease are associated with diminished mucosal alpha-defensin expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2.3.471

A polymorphism in the TNF-alpha promoter gene is associated with pediatric onset and colonic location of Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2.3.471

IL1B gene polymorphisms influence the course and severity of inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2.3.471

IL18 polymorphism is associated with an increased risk of Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2.3.471

A Polymorphism of the Bactericidal/Permeability Increasing Protein (BPI) Gene Is Associated With Crohn??s Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2.3.471

Enteric Microflora in IBD: Pathogens or Commensals?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2.3.471

How the gut senses its content.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2.3.471

Role of cytokines in the pathogenesis of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2.3.471

Review article: oxidative stress as a pathogenic factor in inflammatory bowel disease--radicals or ridiculous?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2.3.471

S100 proteins in mouse and man: from evolution to function and pathology (including an update of the nomenclature)

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2.3.471

The crystal structure of human MRP14 (S100A9), a Ca(2+)-dependent regulator protein in inflammatory process

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2.3.471

High level expression and dimer characterization of the S100 EF-hand proteins, migration inhibitory factor-related proteins 8 and 14.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2.3.471

Evidence for the involvement of the unique C-tail of S100A9 in the binding of arachidonic acid to the heterocomplex S100A8/A9.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2.3.471

Sjögren's syndrome in inflammatory rheumatic diseases: analysis of the leukocyte protein calprotectin in plasma and saliva

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2.3.471

Calprotectin (S100A8/S100A9), an inflammatory protein complex from neutrophils with a broad apoptosis-inducing activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2.3.471

Effects of calprotectin in avridine-induced arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2.3.471

The zinc-reversible antimicrobial activity of neutrophil lysates and abscess fluid supernatants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2.3.471

Zinc-reversible antimicrobial activity of recombinant calprotectin (migration inhibitory factor-related proteins 8 and 14)

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2.3.471

Antimicrobial activity of an abundant calcium-binding protein in the cytoplasm of human neutrophils.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2.3.471

Fungal susceptibility to zinc deprivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2.3.471

Calprotectin, an abundant cytosolic protein from human polymorphonuclear leukocytes, inhibits the growth of Borrelia burgdorferi.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2.3.471

Antimicrobial actions of calcium binding leucocyte L1 protein, calprotectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2.3.471

Calprotectin expression inhibits bacterial binding to mucosal epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2.3.471

Inflammatory cells in the formation of tumor-related sarcoid reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2.3.471

Calcitermin, a novel antimicrobial peptide isolated from human airway secretions

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2.3.471

Oxidation regulates the inflammatory properties of the murine S100 protein S100A8

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2.3.471

Novel intra- and inter-molecular sulfinamide bonds in S100A8 produced by hypochlorite oxidation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2.3.471

Increases in free radicals and cytoskeletal protein oxidation and nitration in the colon of patients with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2.3.471

Immunohistochemical distribution and serum levels of the Ca(2+)-binding proteins MRP8, MRP14 and their heterodimeric form MRP8/14 in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2.3.471

Proinflammatory cytokines upregulate expression of calprotectin (L1 protein, MRP-8/MRP-14) in cultured human keratinocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2.3.471

Neutrophil transmigration in inflammatory bowel disease is associated with differential expression of epithelial intercellular junction proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2.3.471

Increased secretion of pro-inflammatory cytokines by circulating polymorphonuclear neutrophils and regulation by interleukin 10 during intestinal inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2.3.471

Correlation between faecal excretion of indium-111-labelled granulocytes and calprotectin, a granulocyte marker protein, in patients with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2.3.471

Emerging role of calprotectin in gastroenterology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2.3.471

Assessment of the neutrophil dominating protein calprotectin in feces. A methodologic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2.3.471

Is fecal calprotectin the next standard in inflammatory bowel disease activity tests?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2.3.471

Fecal calprotectin: validation as a noninvasive measure of bowel inflammation in childhood inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2.3.471

Diagnostic accuracy of fecal calprotectin assay in distinguishing organic causes of chronic diarrhea from irritable bowel syndrome: a prospective study in adults and children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2.3.471

Role of faecal calprotectin as non-invasive marker of intestinal inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2.3.471

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2.3.471

Distribution of macrophages and granulocytes expressing L1 protein (calprotectin) in human Peyer's patches compared with normal ileal lamina propria and mesenteric lymph nodes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2.3.471

A simple method for assessing intestinal inflammation in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2.3.471

Fecal calprotectin as a measure of disease activity in childhood inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2.3.471

Faecal calprotectin and faecal occult blood tests in the diagnosis of colorectal carcinoma and adenoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2.3.471

Normalization of faecal calprotectin: a predictor of mucosal healing in patients with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2.3.471

Clinical remission in Crohn's disease--assessment using faecal 111In granulocyte excretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2.3.471

Surrogate markers of intestinal inflammation are predictive of relapse in patients with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2.3.471

Calprotectin is a stronger predictive marker of relapse in ulcerative colitis than in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2.3.471

Subclinical intestinal inflammation: an inherited abnormality in Crohn’s disease relatives?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2.3.471

High faecal calprotectin concentrations in newborn infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2.3.471

Age-dependent variations in fecal calprotectin concentrations in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2.3.471

Diagnostic value of faecal calprotectin in paediatric gastroenterology clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2.3.471

Faecal calprotectin concentrations and diagnosis of necrotising enterocolitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2.3.471

Calprotectin levels in meconium

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2.3.471

Total chemical synthesis and chemotactic activity of human S100A12 (EN-RAGE).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2.3.471

Expression of S100A12 (EN-RAGE) in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2.3.471

Monitoring neutrophil activation in juvenile rheumatoid arthritis by S100A12 serum concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2.3.471

Neutrophil derived human S100A12 (EN-RAGE) is strongly expressed during chronic active inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2.3.471

Functional roles of S100 proteins, calcium-binding proteins of the EF-hand type

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2.3.471

RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2.3.471

RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2.3.471

The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of rage and amphoterin in the developing nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2.3.471

RAGE and arthritis: the G82S polymorphism amplifies the inflammatory response

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2.3.471

Plasma levels of soluble receptor for advanced glycation end products and coronary artery disease in nondiabetic men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2.3.471

Blockade of receptor for advanced glycation end product (RAGE) attenuates ischemia and reperfusion injury to the liver in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2.3.471

Ulcerative colitis and Crohn's disease: distinctive gene expression profiles and novel susceptibility candidate genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2.3.471

Review article: the incidence and prevalence of colorectal cancer in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2.3.471

21 January 2018

Identifiers

DOI

10.1586/1744666X.2.3.471

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20476917%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

1 reference